Document:

Distribution Agreement

  
 Exhibit 10.121 
  
 DISTRIBUTION AGREEMENT  
  
 THIS
AGREEMENT is made effective October 10, 2002, by and between Calypte Biomedical Corporation (“Calypte”), incorporated under the laws of Delaware, and Zhong Yang Pute Co.(“DISTRIBUTOR”), incorporated under the laws of
People’s Republic of China. 
  
 WHEREAS, Calypte is a developer and manufacturer of in vitro diagnostic kits and kit components, and
whereas DISTRIBUTOR wishes to commercially distribute said kits and kit components in the Territory; 
  
 In consideration of the mutual
covenants and promises set forth below, and with intent to be legally bound, the parties agree as follows: 
  
 ARTICLE 1 -
DEFINITIONS 
  

	 	(A)
	 
	“Product” shall mean the products listed in Schedule 1 hereof. 
 

  

	 	(B)
	 
	“Territory” shall mean the geographic regions and/or Fields of Use within People’s Republic of China, as described in Schedule 5 and subject to
expansion or reduction pursuant to the terms of this Agreement. 
 

  

	 	(C)
	 
	“Exclusive Distributor” shall mean that no other distributor, regardless of location of principal offices, shall have any rights to commercially
distribute the Products for sale in the Territory. 
 

  

	 	(D)
	 
	“Non-exclusive Distributor” shall mean that one or more distributors may currently, or in the future, have rights to commercially distribute the
Products for sale in the Territory. 
 

  

	 	(E)
	 
	“Trademarks” shall mean those commercial marks listed in Schedule 4 hereof. 
 

  

ARTICLE 2 - APPOINTMENT OF DISTRIBUTOR 
  

	2.0
	 
	APPOINTMENT    Calypte hereby designates and appoints DISTRIBUTOR as Calypte’s Exclusive Distributor in the Territory for the sale,
promotion, support, and distribution of the Products in the Territory, subject to the terms and conditions of this Agreement, with the exception of Cambridge BiotechTM HIV-1 Serum Western Blot, for which DISTRIBUTOR is appointed as Non-Exclusive Distributor in the Territory. Territory extensions will be
considered in good faith by Calypte provided DISTRIBUTOR is in good standing relative to minimum purchases, DISTRIBUTOR can substantiate a clearly defined market opportunity, and provided that Calypte has not already appointed another party for
distribution into the requested territory or field of use. 
 

 
 1 

  

	2.1
	 
	INDEPENDENT CONTRACTOR; LIMITATION OF RIGHTS    Except for the limited purpose set forth herein, nothing in this Agreement shall be deemed
to constitute a partnership between the parties hereto or be deemed to constitute DISTRIBUTOR as agent or employee for Calypte for any purpose, including the right to contract in the name of or for the account of Calypte nor to assume or create any
liability or obligation of any kind, express or implied, on behalf of Calypte in any way or for any purpose. . The relationship between the parties is that of independent contractors in which Calypte is the vendor and DISTRIBUTOR is the vendee. This
Agreement does not constitute a Trademark or other license nor a grant of Trademark or other intellectual property rights, except that DISTRIBUTOR is entitled to use Trademarks solely in connection with the distribution of Products hereunder.

 

  
 ARTICLE 3    TERM 
  

	3.0
	 
	EFFECTIVE DATE    This Agreement shall become effective as of the date first shown in this Agreement. 
 

 

	3.1
	 
	TERM    Unless sooner terminated or unless renewed as provided herein, this Agreement shall terminate on the second anniversary of the
Effective Date. 
 

  

	3.2
	 
	EXTENSION OF TERM    Unless sooner terminated or otherwise renewed as provided herein, DISTRIBUTOR shall have the right to renew this
Agreement for an additional two (2) year period provided: 
 

 i) DISTRIBUTOR meets or exceeds the sales minima detailed in Schedule 3, and

 ii) DISTRIBUTOR notifies Calypte in writing of its intention to renew the Agreement no less than ninety (90) days prior to the date the Agreement would
otherwise terminate, and 
 iii) DISTRIBUTOR has not declined distribution rights for any new Product which Calypte has offered to DISTRIBUTOR during the
term of the Agreement, provided the new Products offered to DISTRIBUTOR are Products which DISTRIBUTOR could be reasonably expected to sell. 
  
 ARTICLE 4    DISTRIBUTOR’S UNDERTAKINGS 
  
 DISTRIBUTOR agrees, at
its sole expense (unless otherwise expressly provided herein), during the term of this Agreement: 
  

	4.1.1
	 
	BEST EFFORTS    At all times to use its best efforts to vigorously and actively market, advertise, promote, and extend the sale of the
Products throughout the Territory. To this end, DISTRIBUTOR agrees to maintain an adequate and competent staff of sales and technical support personnel which can function in all languages of the Territory. All advertisements, brochures, and other
materials distributed in connection with the sale of the Products shall be submitted to Calypte for prior written approval, such approval not to be unreasonably withheld. 
 

  

	4.1.2
	 
	TECHNICAL SUPPORT AND RECALL CAPABILITY    To maintain adequate personnel and laboratory facilities for training, trouble-shooting, and
complaint resolution, such personnel to meet or surpass the standards of Calypte. Further, to 
 

 
 2 

  
 provide to Calypte’s Technical Services department a monthly report
detailing any customer complaint(s) related to performance of the Products, such report to be issued even in the absence of complaints during the reporting period. Complaint reports shall provide full particulars regarding the nature of the
complaint(s) and mechanism(s) of successful resolution. DISTRIBUTOR also certifies that it has, and shall maintain, the capability of tracking Product shipments by lot number in order to execute a Product recall should such a recall be required.

  

	4.1.3
	 
	MINIMA    To purchase in each twelve month period, regardless of the registration status of the Products with the Biologics Division of the
SDA, but provided that the Products can be legally sold within the Territory, the minimum quantities described in Schedule 3 hereof. During any calendar quarter, purchases of Product shall not be less than 15% of the total minimum quantity specified
for that twelve-month period. 
 

  

	4.2
	 
	EXCLUSIVE TERRITORY    Not to solicit customers for any of the Products outside the Territory, either directly or through any third party,
without Calypte’s prior written approval. Furthermore, should it become evident that Product sold by DISTRIBUTOR within the Territory is being resold outside the Territory by any customer of DISTRIBUTOR, to take such action as may be necessary
to discontinue that practice. 
 

  

	4.3.1
	 
	REGISTRATION AND PERMITS    At no charge to Calypte, to provide reasonable assistance to Calypte in the registration of the Products with
the regulatory authorities in the Territory, and to provide reasonable assistance in securing such licenses and registrations which may be required in connection with the importation and sale of the Products in the Territory. Such assistance may
include among others DISTRIBUTOR providing to Calypte, or directly to authorities, such information as may be necessary to permit the importation of Product or components, occasional communication with regulatory authorities, and the coordination of
Product regulatory trials. Such trials may require DISTRIBUTOR to provide instrumentation, laboratory disposables, and the training and monitoring of trial sites. Calypte shall offer such guidance and test kits as may be required and commercially
reasonable in Calypte’s opinion, and upon successful Product registration, Calypte shall reimburse DISTRIBUTOR for its payment of governmental and trial site fees which are directly associated with local registration of the Products, and which
have been pre-approved by Calypte, such approval not to be unreasonably withheld. 
 

  

	4.3.2
	 
	To register the Products in the name of Calypte. 
 

  

	4.3.3
	 
	To hereby certify that local law permits multiple parties, either consecutively or concurrently, to distribute the Products in the Territory. 

  

	4.4.1
	 
	ROLLING DEMAND PURCHASE FORECAST    On a monthly basis, and no later than the first Monday of the month, to provide to Calypte a written
six- 
 

 
 3 

  
  month rolling purchase forecast. The first three months of the forecast shall
constitute an irrevocable commitment to purchase. In this fashion, DISTRIBUTOR commits monthly to one new month of purchases three months in the future. The manufacturing cycle for the Products is at least two months; therefore the first forecast
issued by DISTRIBUTOR under this Agreement shall only be for four months, the first month of which is an irrevocable order for delivery three months in the future. Each individual order for HIV-1 urine EIA shall be for a minimum of 120,000 tests
(the equivalent of 250 480-test kits). 
   

	4.4.2
	 
	SALES REPORTS    To submit to Calypte within thirty days of January 1 and July 1of each year a written summary as to the prevailing market
conditions, the attitudes of customers, the activities of competitors, or any other market conditions which may significantly impact the sales of the Products in the Territory. 
 

  

	4.5.1
	 
	HANDLING OF PRODUCTS    To ensure that the Products are handled, stored, and shipped in accordance with Calypte’s instructions and
local laws. 
 

  

	4.5.2
	 
	To order, and to maintain a representative selection of Calypte’s up-to-date sales literature or other promotional material in good condition.

 

  

	4.5.3
	 
	To maintain such stock of the Products as is reasonably necessary to enable DISTRIBUTOR to comply with its obligations hereunder. 

  

	4.6
	 
	SALES LEADS    To exercise its best judgement to follow up on sales leads supplied by Calypte. 
 

  

	4.7
	 
	CONFIDENTIALITY    Not at any time to divulge to any third party any Confidential Information relating to the Products or to Calypte’s
affairs or business or method of carrying on business, except so far as is necessary, to those authorized to have access to such information within DISTRIBUTOR’s organization. 
 

  
 DISTRIBUTOR    may receive information from Calypte, its personnel, or through DISTRIBUTOR’s activities under
this Agreement, either by direct or indirect communication or observation; more specifically, Calypte will make available to DISTRIBUTOR, after execution of this Agreement, such marketing and quality control data, and other proprietary, secret, and
confidential information owned by Calypte which, in the opinion of Calypte, are necessary for DISTRIBUTOR to sell the Products (herein collectively referred to as “Confidential Information”). 
  
 DISTRIBUTOR    shall not make use of the Confidential Information other than in connection with the marketing and sale
of the Products under this Agreement and shall under no circumstances disclose the Confidential Information to any third party. Except for such of the Confidential Information that becomes publicly available through Calypte or independent third
parties, DISTRIBUTOR shall not use, employ or exploit the Confidential Information, except for the direct benefit 

 
 4 

  
 of Calypte, without Calypte’s written consent for the term of this Agreement
and seven (7) years thereafter. 
  

	4.8
	 
	SUB- DISTRIBUTORS    Not to appoint or subcontract, without the prior written approval of Calypte, any subdistributors or sales
representatives in the Territory in connection with the performance of this Agreement, such approval not to be unreasonably withheld. In the event that Calypte grants such approval, such appointment shall be made only in the name and for the account
of DISTRIBUTOR, shall be for a term no longer than the term of this Agreement, and shall not confer upon such subdistributors and/or independent sales representatives any rights greater than those which are granted by Calypte to DISTRIBUTOR under
this Agreement. DISTRIBUTOR shall also impose on any such subdistributors and/or independent sales representatives the same obligations that Calypte has imposed on DISTRIBUTOR under this Agreement for the purpose of protecting the goodwill of
Calypte and the Products. 
 

  

	4.9
	 
	LEGAL STANDARDS    To advise Calypte in writing of any changes which DISTRIBUTOR becomes aware of in legal standards within the Territory
pertaining to the Products during the term of this Agreement, including but not limited to packaging, labeling and ingredient standards, sufficiently in advance of the imposition of such legal standards as to permit Calypte’s orderly scheduling
and delivery of Product within DISTRIBUTOR’s requested time of shipment. 
 

  

	4.10.1
	 
	LABELING    To ensure that the Products are sold and promoted in the form and with the labeling or markings designated by Calypte, and not
to alter, remove, or interfere therewith without the prior written consent of Calypte. 
 

  

	4.10.2
	 
	DISTRIBUTOR LABELS    Notwithstanding the generality of the foregoing, Calypte hereby authorizes DISTRIBUTOR to affix a small label which
denotes DISTRIBUTOR as the authorized distributor in the Territory, such label to be applied in a manner which does not obscure Calypte’s tradenames or other marks. 
 

  

	4.11.1
	 
	TRADEMARKS    To respect Calypte’s rights in connection with the Products (including but not limited to Calypte’s patents,
trademarks, and copyrights), to comply with all local laws and regulations with respect thereof, and to assist Calypte in taking any steps necessary to defend such rights. Any reasonable expenses incurred under this paragraph by DISTRIBUTOR, and
which are preapproved by Calypte, shall be reimbursed by Calypte. 
 

  

	4.11.2
	 
	To acknowledge at all times Calypte’s exclusive right, title, and interest in and to the trademarks associated with the Products listed in Schedule 1 and
registered by Calypte in the United States of America or the Terrritory; and not at any time to do or cause to be done any act or any thing contesting or in any way impairing or tending to impair any part of such right, title and interest. In
connection with any reference to the trademarks, DISTRIBUTOR shall not in any manner represent that it has ownership interest in the trademarks or registration thereof, but shall clearly indicate Calypte’s ownership of the trademarks.

 

 
 5 

  

	4.11.3
	 
	To use no trademarks, trade names, corporate names, or trade styles employing the trademarks, whether in advertising or otherwise, without the prior written
consent of Calypte, such consent not to be unreasonably withheld, and generally not to produce any advertising or promotional material or activity without Calypte’s written consent. Except as provided in Article 9.2, any and all use by
DISTRIBUTOR of said trademarks, trade names, corporate names or trade styles within the Territory shall cease upon the expiration or termination of this Agreement. 
 

  

	4.12
	 
	PRESS    To make no statements to the press concerning Calypte’s personnel, business practices, Product development efforts, or alleged
Product performance problems without the prior written consent of Calypte. 
 

  

	4.13
	 
	MANAGEMENT CHANGE    To provide to Calypte prompt notice, in writing, of any change of key management or ownership and any change in the
mode of operation of DISTRIBUTOR. 
 

  

	4.14
	 
	PROOF OF SALE    To expressly represent that any Products purchased are for the purpose of sale in the Territory and will furnish upon
Calypte’s requests, documents which certify that the Products have been sold in that Territory. DISTRIBUTOR further represents that it will undertake all appropriate steps to ensure that the Products are sold exclusively to customers which are
permitted under the laws of the Territory to purchase and use the Products. 
 

  

	4.15
	 
	AUDIT    To permit Calypte staff or a Calypte designee, upon reasonable advance notice, to audit DISTRIBUTOR’s premises and sales
records in connection with this Agreement at no expense to DISTRIBUTOR. 
 

  

	4.16
	 
	COMPETING PRODUCTS    During the term of this Agreement, neither directly nor through any third party to manufacture, sell, promote, market,
or advertise without prior written permission from Calypte, any in vitro diagnostic test for the detection of HIV antibodies in bodily fluids other than serum or plasma.  
 

  

	4.17
	 
	NEW PRODUCTS    To accept distribution rights and obligations for new Products which the parties believe DISTRIBUTOR could be reasonably
expected to sell as they may become available from time to time, and under such terms and conditions as the parties may negotiate in good faith. 
 

  
 ARTICLE 5    CALYPTE’S UNDERTAKINGS 
  
 Calypte agrees,
during the term of this Agreement: 
  

	5.1.1
	 
	EXCLUSIVE DISTRIBUTOR    To limit the authorized sale of the Products in the Territory to DISTRIBUTOR, and to take such action as may be
necessary to ensure compliance of third parties in this regard. Exclusively in connection with 
 

 
 6 

 this section 5.1.1, Calypte shall permit DISTRIBUTOR staff or a DISTRIBUTOR designee, upon reasonable advance notice, to
audit Calypte’s sales records. 
  

	5.2
	 
	FILLING ORDERS    To use its best efforts to fill all orders of DISTRIBUTOR for delivery of the Products hereunder. Orders shall be placed
in writing and mailed or transmitted by facsimile in accordance with the Rolling Demand Forecasting system described in Section 4.4.1 hereof. No order from DISTRIBUTOR shall be binding upon Calypte until such order is accepted by Calypte in writing
by mail or facsimile, such acceptance not to be unreasonably withheld and to be issued within 5 working days of receipt of order. Calypte shall make commercially reasonable efforts to fill orders which are placed by DISTRIBUTOR in addition to the
orders placed through the Rolling Demand Forecasting system. 
 

  

	5.3
	 
	TRADEMARKS    To use its best efforts to maintain the Trademarks in good legal standing in the Territory. 

  

	5.4
	 
	SALES MATERIAL    To furnish to DISTRIBUTOR, at Calypte’s expense, a reasonable supply of sales literature and promotional materials.
The promotional materials may be furnished in the English language. DISTRIBUTOR may translate the materials at its own expense, and with prior approval from Calypte, such approval not to be unreasonably withheld, provided that Calypte will own all
rights to all such translations. Calypte may make reasonable charges if more than a nominal quantity of promotional materials is supplied to DISTRIBUTOR, which will be agreed upon between Calypte and DISTRIBUTOR in advance. Calypte agrees to
reimburse DISTRIBUTOR for the production of reasonable quantities of Calypte-approved Chinese promotional literature on the condition that Calypte accepts the marketing value of Chinese promotional pieces proposed by DISTRIBUTOR, and on the
condition that the promotional pieces can be produced at a cost equal to, or lower than the cost of Calypte’s own English materials. 
 

  

	5.5
	 
	WARRANTY    To warrant the Products as set out in Article 8 below. 
 

  

	5.6
	 
	SALES LEADS    To forward to DISTRIBUTOR sales leads and inquiries from customers located within the Territory. 

  

	5.7
	 
	TRAINING    To provide to DISTRIBUTOR such sales, marketing, and technical training as may be reasonably required, at Calypte’s
facility, but not to exceed one week during each year of this Agreement. Costs incurred in such training excluding travel and accommodation, but including training materials, trainer time, and a reasonable amount of Product shall be borne by
Calypte. 
 

  

	5.8
	 
	To provide telephone technical support in English to DISTRIBUTOR during Calypte’s normal business hours. 
 

 
 7 

  

	5.9
	 
	NEW PRODUCTS    To offer to DISTRIBUTOR the opportunity to apply for distribution rights on new products which Calypte may develop from time
to time. DISTRIBUTOR’s application shall be reviewed in good faith by Calypte with respect to DISTRIBUTOR’s historical performance and new product sales forecasts, and subject to such limitations as may be imposed upon Calypte by third
parties that are integral to the development of such new products. 
 

  

	5.10
	 
	NO-CHARGE EVALUATION MATERIALS    To provide to DISTRIBUTOR over the first two years of the Agreement, as evaluation materials not to be
sold or transferred by DISTRIBUTOR without Calypte’s prior consent, such consent not to be unreasonably withheld, a maximum allocation of 10% of the first year’s minimum and 7% of the second year’s minimum at no charge to DISTRIBUTOR
other than the shipping. 
 

  
 ARTICLE 6    PRICE AND
PAYMENT 
  

	6.1
	 
	PRICE AND PAYMENT    All prices are F.O.B. Calypte’s relevant manufacturing facilities. Any and all import permits, licenses, lot
release fees, or any other authorizations required to be obtained from any ministry, agency, bank or institute within the Territory to effect the importation of the Products, including but not limited to their clearance through the corresponding
customs and health authorities, will be secured and done or caused to be secured and done by DISTRIBUTOR at DISTRIBUTOR’S expense. Any and all additional expenses including, but not limited to taxes and customs duties which may be incurred in
acting under this Agreement are to be similarly borne and paid by DISTRIBUTOR. 
 

  

	6.2
	 
	MAXIMUM MARK-UP    To ensure that Calypte Products are sold at prices that are competitive, and which facilitate widespread Product use,
DISTRIBUTOR agrees to limit its mark-up to customers and distributors to 20%, such mark-up to be calculated after allowances for shipping and insurance, duties, lot release fees, and taxes. The parties agree to review the maximum mark-up provision
annually, not less than 30 days prior to the anniversary of this Agreement. 
 

  

	6.3
	 
	TERMS OF PAYMENT    Terms of payment for the Products sold by Calypte to DISTRIBUTOR hereunder shall be by irrevocable standby Letter of
Credit, wire transfer or similar financial vehicle, payable in advance. 
 

  

	6.4
	 
	CURRENCY    Payment shall be made in U.S. dollars. 
 

  

	6.5
	 
	PRICE CHANGES    Calypte reserves the right to change the price of any or all Products no more than once per Product per 12-month period of
the Agreement. Calypte agrees to lower the price of Products to DISTRIBUTOR as it deems appropriate in the event that Calypte achieves significant production cost reductions through production efficiencies or local production. 

  
 ARTICLE 7    SHIPPING-TITLE AND RISK-CANCELLATION

 
 8 

  

	7.1
	 
	RISK OF LOSS    Calypte’s obligation to effect shipment of the Products shall be fully discharged upon delivery of Products to the
carrier, and title to, and all risk of damage or loss to the Products shall pass to DISTRIBUTOR at this time. Shipments shall be insured at the option and expense of DISTRIBUTOR. 
 

  

	7.2
	 
	DELIVERY    Calypte shall use its best efforts to ship the Products to DISTRIBUTOR in accordance with DISTRIBUTOR’s shipping
instructions. The completion of the formalities pertaining to the entry of the Products into the Territory, as well as the payment of any taxes, duties, or charges relating to same, shall be the sole responsibility of DISTRIBUTOR. 

  
 ARTICLE 8    WARRANTY - NO CONSEQUENTIAL DAMAGES - INDEMNITY 
  

	8.1
	 
	WARRANTY    Calypte warrants the Products to be of sufficient quality of materials and manufacture as to meet the claims and specifications
set forth in the Product’s packaging and labeling when used according to the directions provided therein. 
 

  
 EXCEPT AS OTHERWISE EXPRESSLY PROVIDED HEREIN, CALYPTE MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING FITNESS FOR A PARTICULAR PURPOSE, OR ANY OTHER MATTER, WITH RESPECT TO THE PRODUCTS.
DISTRIBUTOR’s exclusive remedy will be for direct damages, and Calypte’s total liability for any and all losses and damages arising out of any cause whatsoever (whether such cause be based in contract, warranty, negligence, strict
liability, other tort or otherwise) will in no event exceed DISTRIBUTOR’s landed cost of the Products in respect to which such cause arises or, at Calypte’s option, the replacement of such Products. In no event will Calypte be liable for
incidental, consequential or punitive damages resulting from any cause whatsoever. Calypte warrants that at the time that the Products left Calypte’s possession, they were deemed to be of good quality. 
  

	8.2
	 
	DEFECTS    Without limiting the generality of the foregoing, CALYPTE SHALL NOT BE BOUND TO MAKE GOOD ANY DEFECT IN THE PRODUCTS WHERE THE
PRODUCTS HAVE BEEN SUBJECTED TO MISUSE, NEGLECT, OR ACCIDENTAL DAMAGE AFTER DELIVERY BY CALYPTE TO THE CARRIER. 
 

  

	8.3
	 
	TRADEMARKS    Calypte is the record owner of registrations for its trademarks in the Territory and believes it has the right to use these
trademarks throughout the Territory. Notwithstanding, CALYPTE MAKES NO EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY THAT THE PRODUCTS WILL NOT INFRINGE THE LEGITIMATE AND VALID TRADEMARKS, TRADE NAMES, OR OTHER INDUSTRIAL PROPERTY RIGHTS OF THIRD
PARTIES IN THE TERRITORY. DISTRIBUTOR shall immediately notify 
 

 
 9 

 Calypte of any such claims of others, and Calypte shall, at its sole option, have the right to assume the defense of any
such claim. 
  

	8.4
	 
	INSPECTION    It shall be the responsibility of DISTRIBUTOR to inspect the Products after taking title to same. Notwithstanding Article 8.1
above, Calypte shall not be liable for any shortage, breakage, or damage to the Products or for any breach of warranty, implied or otherwise, unless it receives written notice of any defect or shortcoming within ten (10) days after the date on which
DISTRIBUTOR receives the Products, and the defect or shortcoming results from the fault or negligence of Calypte. 
 

  

	8.5
	 
	INDEMNIFICATION    Calypte shall indemnify and hold DISTRIBUTOR harmless from any claims, demands, liabilities, suits or expenses of any
kind arising out of any misrepresentations which Calypte makes concerning the Product supplied by Calypte. 
 

  
 Calypte shall indemnify DISTRIBUTOR for any damages or loss actually paid by DISTRIBUTOR resulting from a final, non-appealable legal decision on a claim by third parties made against DISTRIBUTOR and to the extent to which is found
by such decision to have been caused by Calypte with respect to Products made or supplied by Calypte. 
  
 DISTRIBUTOR
is responsible for, and shall hold Calypte harmless from any loss, claim, damage, illness or injury to persons or property which arises out of or pertains to the sale, use, packaging, advertising, or promotion of the Product, and which is caused by
DISTRIBUTOR or DISTRIBUTOR’s subdistributors, agents or employees. This provision shall survive the expiration or termination of this Agreement for any reason and shall be liberally construed in favor of Calypte. 
  
 ARTICLE 9    TERM AND TERMINATION 
  

	9.1.1
	 
	TERMINATION FOR CAUSE    Calypte, at its sole option, may immediately terminate this Agreement with respect to the Territory, upon giving
written notice to DISTRIBUTOR to this effect, whenever any of the following events occurs: 
 

  
 (i)
if any governmental unit within the Territory threatens (in the sole judgement of Calypte) to enact, or enacts, any law, decree or regulation which would restrict the right of Calypte to terminate or elect not to renew this Agreement as herein
provided, or would make Calypte liable to DISTRIBUTOR for compensation or damages upon termination or failure to renew this Agreement; 
  
 (ii) if DISTRIBUTOR at any time discontinues or abolishes its business, files a petition of bankruptcy or insolvency or admits in writing its inability to pay its debts as they become due and payable, or if DISTRIBUTOR is
adjudicated bankrupt or insolvent, or if there is filed any petition seeking reorganization of DISTRIBUTOR, or if a receiver is appointed for all or substantially all of DISTRIBUTOR’s property, or if DISTRIBUTOR makes an assignment for the

 
 10 

 benefit of creditors or if any proceedings are instituted for the liquidation or winding up of DISTRIBUTOR; 

 
 (iii) if DISTRIBUTOR uses Calypte’s trademarks or trade names or styles in any way which in Calypte’s sole judgement
might deceive or mislead the consumer or which might in any way damage or impair the reputation or value of such trademarks, trade names, or styles; 
  
 (iv) if DISTRIBUTOR fails to comply with any of the terms or conditions herein contained and, after notice by Calypte requiring DISTRIBUTOR to make good such default, DISTRIBUTOR fails to cure such
default within thirty (30) days after receipt of such notice; 
  
 (v) if DISTRIBUTOR is at any time nationalized or
falls under the control of any governmental unit within the Territory;  
  
 (vi) if DISTRIBUTOR’s
authority to carry on business is cancelled by competent authorities; 
  
 (vii) if control of DISTRIBUTOR should be
transferred to another party, whether such party is a competitor of Calypte or otherwise; or 
  
 (viii) all Products
are deleted from Schedule 1. 
  
 (ix) Calypte, at its discretion, may choose to forego outright termination of
DISTRIBUTOR in favor of the selective reduction or renegotiation of Territory or Minima based on Calypte’s analysis of DISTRIBUTOR’S sales reports relative to the sales target listed in Schedule 6. 
  

	9.1.2
	 
	DISTRIBUTOR, at its sole option, may immediately terminate this Agreement with respect to the Territory, upon giving written notice to Calypte to this effect,
whenever any of the following events occurs: 
 

  
 (i) if Calypte at any time discontinues or
abolishes its business, files a petition of bankruptcy or insolvency or admits in writing its inability to pay its debts as they become due and payable, or if Calypte is adjudicated bankrupt or insolvent, or if there is filed any petition seeking
reorganization of Calypte, or if a receiver is appointed for all or substantially all of Calypte’s property, or if Calypte makes an assignment for the benefit of creditors or if any proceedings are instituted for the liquidation or winding down
of Calypte; or 
  
 (ii) if Calypte fails to comply with any of the terms or conditions herein contained and, after
notice by DISTRIBUTOR requiring Calypte to make good such default, Calypte fails to cure such default within thirty (30) days after receipt of such notice. 

 
 11 

  

	9.1.3
	 
	TERMINATION FOR CONVENIENCE    Each party reserves the right, upon not less than 90 days’ written notice to the other to terminate this
Agreement at its sole discretion, without cause. 
 

  

	9.1.4
	 
	TERRITORY LAWS    If Calypte determines that the appointment or use of DISTRIBUTOR is not permitted under the laws and regulations in force
in the Territory, Calypte has the right, at its sole discretion and upon notice to DISTRIBUTOR, to terminate this Agreement as Calypte sees fit. Upon notice of this decision, DISTRIBUTOR will cease its activities under this Agreement and shall not
seek damages or compensation in any form, according to Article 9 of this Agreement. 
 

  

	9.2.1
	 
	Upon termination or expiration of this Agreement for any reason other than Termination for Convenience with respect to the Territory: 

  
 i) at Calypte’s option, DISTRIBUTOR may sell its remaining inventory of Product within the Territory,
or shall make available to Calypte or Calypte’s designee, all current stocks of Product held by DISTRIBUTOR with a minimum of four (4) months’ expiration remaining, at DISTRIBUTOR’s landed cost, FOB DISTRIBUTOR’s warehouse, which
shall include any duty, freight, insurance documentation and inland freight to warehouse distribution. 
  
 ii)
DISTRIBUTOR shall at its own expense return to Calypte or its designee all Confidential Information furnished by Calypte in accordance with Article 5.2 hereof, as well as all sales literature, catalogues, samples, and other promotional materials
supplied by Calypte; 
  
 iii) Calypte will not be liable to pay to DISTRIBUTOR any termination compensation, benefits
or damages of any kind whatsoever, whether for DISTRIBUTOR’s loss of present or prospective profits, anticipated sales, expenditures, investments or commitments made in connection with this Agreement, or due to the termination of any of
DISTRIBUTOR’s employees, agents, or subdistributors, or due to any other matter or cause whatsoever, and whether provided by any current or future law, regulation or interpretation thereof by any authority exercising jurisdiction over this
Agreement, and; 
  
 iv) all obligations of Calypte shall be canceled, but such expiration or termination will not
affect any of Calypte’s rights hereunder, and Calypte will further have the right, immediately upon such expiration or termination, to appoint a new distributor or sales representative. Such expiration or termination will not affect
DISTRIBUTOR’s obligation to make payment for any orders of the Products which remain unpaid at such time. 
  

	9.2.2
	 
	Upon Termination for Convenience by Calypte with respect to the Territory, the provisions of 9.2.1 shall apply except for provision 9.2.1 i), which shall be
replaced by 9.2.2 i) below: 
 

 
 12 

 i) at DISTRIBUTOR’s option, DISTRIBUTOR may sell its remaining inventory of Product within the Territory, or shall
make available to Calypte or Calypte’s designee, all current stocks of Product held by DISTRIBUTOR with a minimum of ten (10) weeks’ expiration remaining, at DISTRIBUTOR’s landed cost, FOB DISTRIBUTOR’s warehouse, which shall
include any duty, freight, insurance documentation and inland freight to warehouse distribution. 
  
 ARTICLE
10    ASSIGNMENT 
  
 DISTRIBUTOR shall not be entitled to assign its rights and
obligations under this Agreement without the prior written consent of Calypte. In the context of this Agreement, a change in control or ownership of the DISTRIBUTOR, whether involving a competitor of Calypte or otherwise, shall constitute
assignment, and in accordance with 9.1.1(vii) Calypte may, at its discretion, terminate this Agreement. 
  
 ARTICLE
11    WAIVER     
  
 The failure of either party to assert a right
under, or to enforce at any time or for any period of time, the provisions hereof or the failure of either party to exercise an option herein shall not be construed as a waiver of such provision or option and shall in no way affect that party’s
right to enforce such provisions or exercise such options. A waiver of any breach of any provision of this agreement shall not be construed as a continuing waiver of other breaches of the same or other provisions of this agreement. 

 
 ARTICLE 12    ENTIRE AGREEMENT 
  
 With the exception of previously signed Confidentiality Agreements which will continue in effect as to the matters governed hereby, this Agreement cancels and supersedes
any previous understandings or agreements, oral or written, between the parties relating to the subject matter hereof, including any previously existing distributorship arrangement. This Agreement expresses the complete and final understanding of
the parties with respect to the subject matter hereof, and may not be changed in any way except upon the explicit intention of both parties expressed by a signed written agreement. Any terms or conditions stated in DISTRIBUTOR’s purchase orders
inconsistent with this Agreement shall be null and void. 
  
 ARTICLE 13    SEVERABILITY 

 
 If any provision of this Agreement shall be found by a court of competent jurisdiction to be invalid or unenforceable, the
invalidity or unenforceability of such provision shall not affect the other provisions of this Agreement and all provisions not affected by such invalidity shall remain in full force and effect but that in any event, the provisions concerning
payment for the Product shall be binding upon the parties. 
  
 ARTICLE 14    NOTICES 

 
 13 

	14.1
	 
	NOTICE Any notice required or permitted by this Agreement shall be in writing and in the English language, and shall be delivered personally or by registered
air mail, postage prepaid, or by facsimile, addressed to the parties as follows: 
 

  
 
	 If to Calypte:
 	  	 Calypte Biomedical Corporation
 
	  	  	 1265 Harbor Bay Parkway
 Alameda, California 94502
 United States of America
 
	 
	  	  	 Facsimile: 510-814-8408
 
	 
	  	  	 Attention: President
 
	  	  	  
	 
	 If to DISTRIBUTOR:
 	  	 Zypute Bio-Medi-Tech Corp.
 Suite 510-511 Angel Office Bldg.
 6 Ritan Street, Chaoyang District
 Beijing 100020
 People’s Republic of China
 
	 
	  	  	 Facsimile: 011 86 10 6426 2714
 
	 
	  	  	 Attention: President
 

 
  

	14.2
	 
	RECEIPT    Any notice sent by registered prepaid air mail properly addressed and posted shall be deemed to have been received ten (10) days
after it is delivered to the postal authorities in the country of the party by whom it is sent. If sent by facsimile, a copy of the facsimile shall be sent promptly by registered prepaid air mail to the addressee. 
 

 

	14.3
	 
	VERBAL NOTICE    Nothing contained herein shall justify or excuse failure to give verbal notice for the purpose of informing the other party
thereof when prompt notification is appropriate, but such verbal notice shall not satisfy the requirement of written notice. 
 

  
 ARTICLE 15    APPLICABLE LAWS 
  

	15.1
	 
	EXPORT LAWS    Calypte is subject to U.S. laws and regulations governing the export of U.S. products. DISTRIBUTOR agrees that it will not
directly or indirectly engage in any acts which would cause Calypte to be found in violation of such laws or regulations. 
 

  

	15.2
	 
	PAYMENTS DISTRIBUTOR acknowledges that certain laws of the United States may result in the imposition of sanctions on Calypte and its employees in the event
that offers, promises, or payments are directly or indirectly made to government officials or others for the purpose of influencing decisions favorable to Calypte, and, therefore DISTRIBUTOR agrees that neither it nor its employees 

 
 14 

  
 will commit such acts or engage in such activities and that DISTRIBUTOR shall
defend, indemnify, and hold Calypte harmless for any damages, claims, liabilities and expenses which arise or allegedly arise from DISTRIBUTOR’s violation of the obligations of articles 15.1 or 15.2. 
  

	15.3
	 
	ASSURANCES DISTRIBUTOR agrees to furnish to Calypte, by affidavit or other reasonable means from time to time at Calypte’s request, and to the reasonable
satisfaction of Calypte, assurances that the appointment of DISTRIBUTOR hereunder, its activities under this Agreement, and the payment to DISTRIBUTOR of any monies or consideration contemplated hereunder are proper and lawful under the laws in
force in the Territory. DISTRIBUTOR further represents that no person employed by it is an official of any government agency or a corporation owned by a government unit within the Territory and that no part of any monies or consideration paid
hereunder shall accrue for the benefit of any such official. 
 

  
 ARTICLE 16    GOVERNING
LAW; LANGUAGE 
  
 This Agreement and the obligations of the parties hereunder shall be governed and construed in
accordance with the laws of the State of California, U.S.A. If this Agreement is translated into any language other than English, then the English language version hereof will control. 
  
 ARTICLE 17    FORCE MAJEURE 
  
 Calypte and DISTRIBUTOR will be excused from failure to perform under this Agreement and will not be liable in any way for any loss if such failure is due to causes beyond the reasonable control of either party, including but not
limited to, natural disasters such as earthquakes or floods, fires, riots, strikes and other labor disputes, war conditions, shortage of raw materials or government action for the period any such conditions exist. 

 
 15 

  
 ARTICLE 18    HEADINGS

  
 The headings used herein are for convenience only and in no way affect the liabilities, obligations, or
responsibilities of the parties hereto. 
  
 IN WITNESS WHEREOF, the parties hereto have executed
this Agreement. 
  
 CALYPTE BIOMEDICAL CORPORATION 
  
 By:     /s/ Nancy E. Katz
                               
  
 Title:  President and CEO             
               
  
 Date:    September 12, 2002                         
  
 Zhong Yang Pute Biomedical Co. 
  
 By:     /s/ Ji Biao         
                                   
  
 Title:  President         
                                    
  
 Date:     September 19, 2002         
               

 
 16 

  
 SCHEDULE 1 – PRODUCTS 
  

Calypte HIV-1 Urine EIA Test Kit An enzyme immunoassay in microwell format for the detection of antibodies to HIV-1 in urine. 
  
 
	 Cat. No. 700010
 	  	 480 tests
 
	 Cat. No. 700011
 	  	 192 tests
 

 
  
 Cambridge Biotech HIV-1 Serum Western Blot Test Kit. A Western Blot supplemental
immunoassay for the analysis of serum or plasma samples that are repeatedly reactive on a serum or plasma HIV-1 EIA. Cat. No. 98002    27 tests 
  
 Cambridge Biotech HIV-1 Urine Western Blot Test Kit. A Western Blot supplemental immunoassay for the analysis of urine samples that are repeatedly reactive on the Calypte HIV-1 Urine EIA. Cat. No.
98076    27 tests 
  
  SCHEDULE 2 – PRICE 
   
  
	 PRODUCT
 
	  	 KIT SIZE
 
	  	 PRICE/KIT
 

	 Calypte HIV-1 EIA Cat. No. 700010
 	  	 480 tests
 	  	 432.00
 
	 Calypte HIV-1 EIA Cat. No. 700011
 	  	 192 tests
 	  	 250.00
 
	 Cambridge Biotech Cat. No. 98002
 	  	 27 tests
 	  	 567.00
 
	 HIV-1 Serum Western Blot
 	  	  	  	  
	 Cambridge Biotech Cat. No. 98076
 	  	 27 tests
 	  	 513.00
 
	 HIV-1 Urine Western Blot
 	  	  	  	  

 
   
  SCHEDULE 3 – MINIMA 
   
  Minimum purchases of Calypte HIV-1 EIA per twelve month period: 
   
  First twelve month period: 1,500,000 tests 
   
  Second twelve month period: 2,500,000 tests 
   
  Minimum
purchases of Cambridge Biotech HIV-1 Western Blot (in total) per twelve month period: 
   
  First twelve month period: 15,000 tests (555 kits) 
   
  Second twelve month
period: 30,000 tests (1,100 kits) 
   
  DISTRIBUTOR shall purchase no less than 15% of the pertinent 12-month
total in each Agreement quarter. 

 
 17 

  
 SCHEDULE 4 – TRADEMARKS 
  
 Calypte name and corporate logo 
 Calypte
hummingbird logo 
 Sentinel tradename 
 Cambridge Biotech name and corporate logo 
  
 SCHEDULE 5 – TERRITORY 
  
 Any Field of Use operated by the military forces of People’s Republic of China, plus any Field of Use in the following provinces: Beijing, Shanghai,
Jiangsu, Zhejiang, Hubei, Hebei, Henan, Shanxi, Shaanxi, Nei Mongol, Liaoning, Sichuan, Shandong, Guangdong, Helongjiang, Anhui, Guanggong, Fujian, and Tianjinwith the exception of the Drug Rehabilitation / Criminal Justice Field of Use.

  
 SCHEDULE 6 – SALES TARGETS WITHIN THE TERRITORY 
  

Estimated % of sales within the Territory, projected by end of Term: 
   
  
	 Beijing
 	  	 12
 	 %
 
	 Shanghai
 	  	 11
 	 %
 
	 Jiangsu
 	  	 6
 	 %
 
	 Zhejiang
 	  	 5
 	 %
 
	 Hubei
 	  	 5
 	 %
 
	 Hebei
 	  	 5
 	 %
 
	 Henan
 	  	 6
 	 %
 
	 Shanxi
 	  	 4
 	 %
 
	 Shaanxi
 	  	 1
 	 %
 
	 Nei Mongol
 	  	 0.5
 	 %
 
	 Liaoning
 	  	 4
 	 %
 
	 Sichuan
 	  	 5
 	 %
 
	 Shandong
 	  	 5
 	 %
 
	 Guangdong
 	  	 6
 	 %
 
	 Helongjiang
 	  	 4.5
 	 %
 
	 Anhui
 	  	 1
 	 %
 
	 Guangxi
 	  	 2
 	 %
 
	 Fujian
 	  	 2.2
 	 %
 
	 Jianxi
 	  	 1
 	 %
 
	 Tianjin
 	  	 5.5
 	 %
 

 
   
 
	  
 Military sales in the above-listed territory
  
	  	  
 5.3
  
	  
 %
  

	  
 Military in provinces not listed above
  
	  	  
 3
  
	  
 %
  

 

 
 18Form of Warrant Agreement

 
Exhibit 4.10

 
BLACK HILLS CORPORATION 
 
and 
 
                        , 
 
as Warrant Agent 
 

 
WARRANT
AGREEMENT 
 
Dated as of
                     
 
 

 
Warrants to Purchase              
 

 

 
TABLE OF
CONTENTS 

	  	   	  	   	  PAGE

	  ARTICLE I
  ISSUANCE OF WARRANTS AND EXECUTION AND
  DELIVERY OF WARRANT CERTIFICATES

	
	  SECTION 1.01.
	   	  Issuance of Warrants
	   	  2

	  SECTION 1.02.
	   	  Execution and Delivery of Warrant Certificates
	   	  2

	  SECTION 1.03.
	   	  Issuance of Warrant Certificates
	   	  3

	
	  ARTICLE II

	  WARRANT PRICE, DURATION AND EXERCISE OF
WARRANTS

	
	  SECTION 2.01.
	   	  Warrant Price
	   	  4

	  SECTION 2.02.
	   	  Duration of Warrants
	   	  4

	  SECTION 2.03.
	   	  Exercise of Warrants
	   	  4

	
	  ARTICLE III

	  OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS
OF WARRANT

	
	  SECTION 3.01.
	   	  No Rights as Warrant Securityholder Conferred by Warrant or Warrant Certificates
	   	  6

	  SECTION 3.02.
	   	  Lost, Mutilated, Stolen, or Destroyed Warrant Certificates
	   	  6

	  SECTION 3.03.
	   	  Enforcement of Rights
	   	  6

	  SECTION 3.04.
	   	  Merger, Consolidation, Conveyance or Transfer
	   	  7

	
	  ARTICLE IV

	  EXCHANGE AND TRANSFER

	
	  SECTION 4.01.
	   	  Exchange and Transfer
	   	  7

	  SECTION 4.02.
	   	  Treatment of Holders of Warrant Certificates
	   	  8

	  SECTION 4.03.
	   	  Cancellation of Warrant Certificates
	   	  8

	
	  ARTICLE V

	  CONCERNING THE WARRANT
AGENT

	
	  SECTION 5.01.
	   	  Warrant Agent
	   	  9

	  SECTION 5.02.
	   	  Conditions of Warrant Agent's Obligations
	   	  9

	  SECTION 5.03.
	   	  Resignation and Appointment of Successor
	   	  11

	
	  ARTICLE VI

	  MISCELLANEOUS

	
	  SECTION 6.01.
	   	  Amendment
	   	  12

 

i 

 

	  SECTION 6.02.
	   	  Notices and Demands to the Company and Warrant Agent
	   	  13

	  SECTION 6.03.
	   	  Addresses
	   	  13

	  SECTION 6.04.
	   	  Applicable Law
	   	  13

	  SECTION 6.05.
	   	  Delivery of Prospectus
	   	  13

	  SECTION 6.06.
	   	  Obtaining of Governmental Approval
	   	  13

	  SECTION 6.07.
	   	  Persons Having Rights under Warrant Agreement
	   	  13

	  SECTION 6.08.
	   	  Headings
	   	  14

	  SECTION 6.09.
	   	  Counterparts
	   	  14

	  SECTION 6.10.
	   	  Inspection of Agreement
	   	  14

	  SECTION 6.11.
	   	  Notices to Holders of Warrants
	   	  14

	
	  EXHIBIT A—Form of Warrant Certificate
	   	  

 
 

ii 

 
WARRANT
AGREEMENT1 
 
THIS AGREEMENT dated as of              between BLACK HILLS CORPORATION, a
corporation duly organized and existing under the laws of the State of South Dakota (the “Company”), and             , a [bank] [trust company] duly incorporated and existing
under the laws of            , as Warrant Agent (the “Warrant Agent”). 
 
[Bracketed language here and throughout this Agreement should be inserted as follows: 
 
1.    If Warrants are immediately
detachable from the Offered Securities; and 
 
2.    If Warrants are detachable from the Offered Securities only after the Detachable Date.] 
 
WITNESSETH: 
 
[WHEREAS, the Company has entered into an Indenture dated as of             
(the “Senior Indenture”) between the Company and             , as Trustee (the “Senior Indenture Trustee”), and an Indenture dated as of
             (the “Subordinated Indenture”) between the Company and             , as Trustee (the “Subordinated
Indenture Trustee”) (together, the “Trustees” or “Trustee” and “Indentures” or “Indenture”), providing for the issuance from time to time of its unsecured debt securities to be issued in one or more
series as provided in the Indenture; and] 
 
WHEREAS, the Company proposes to sell [[title of such securities being offered] (the “Offered Securities”) with] one or more warrants (the “Warrants”) representing the right to purchase [title of such securities
purchasable through exercise of Warrants] (the “Warrant Securities”), the Warrants to be evidenced by Warrant certificates issued pursuant to this Agreement (the “Warrant Certificates”); and 
 
WHEREAS, the Company desires the Warrant Agent to act on
behalf of the Company in connection with the issuance, transfer, exchange, exercise and replacement of the Warrant Certificates, and in this Agreement wishes to set forth, among other things, the form and provisions of the Warrant Certificates and
the terms and conditions on which they may be issued, transferred, exchanged, exercised and replaced; 
 
NOW, THEREFORE, in consideration of the premises and of the mutual agreements herein contained, the parties hereto agree as follows:

	  1 	  	 Complete or modify the provisions of this form as appropriate to reflect the terms of the Warrants and Warrant Securities. Monetary amounts may be in U.S. dollars
or in foreign currency. 

 
ARTICLE I

 
ISSUANCE OF WARRANTS AND EXECUTION AND

DELIVERY OF WARRANT CERTIFICATES 
 
SECTION 1.01.    Issuance of Warrants.    The Warrants shall be evidenced by one or more
Warrant Certificates. Each Warrant evidenced thereby shall represent the right, subject to the provisions contained herein and therein, to purchase [             shares of the Warrant
Securities] [$            aggregate principal amount of Warrant Securities] and shall be initially issued in connection with the issuance of the Offered Securities [1: and shall be
separately transferable immediately thereafter] [2: but shall not be separately transferable until on and after             , (the “Detachable Date”)]. [The Warrants shall be
initially issued [in units] with the Offered Securities, and] each Warrant [included in such a unit] shall evidence the right, subject to the provisions contained herein and in the Warrant Certificates, to purchase
[             shares of the Warrant Securities] [$             aggregate principal amount of Warrant Securities] [included in
such a unit]. 
 
SECTION
1.02.    Execution and Delivery of Warrant Certificates.    Each Warrant, whenever issued, shall be evidenced by a Warrant Certificate in registered form, substantially in the form set forth in Exhibit
A hereto, shall be dated and may have such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed or engraved thereon as the officers of the Company executing the same may approve
(execution thereof to be conclusive evidence of such approval) and as are not inconsistent with the provisions of this Agreement, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or
regulation of any stock exchange on which the Warrants may be listed, or to conform to usage. The Warrant Certificates shall be signed on behalf of the Company by its chairman or vice chairman of the Board of Directors, the president, any managing
director or the treasurer of the Company, in each case under its corporate seal, which may but need not be, attested by its secretary or one of its assistant secretaries. Such signatures may be manual or facsimile signatures of such authorized
officers and may be imprinted or otherwise reproduced on the Warrant Certificates. The corporate seal of the Company may be in the form of a facsimile thereof and may be impressed, affixed, imprinted or otherwise reproduced on the Warrant
Certificates. 
 
No Warrant Certificate shall be
valid for any purpose, and no Warrant evidenced thereby shall be exercisable, until such Warrant Certificate has been countersigned by the Warrant Agent by manual signature. Such signature by the Warrant Agent upon any Warrant Certificate executed
by the Company shall be conclusive evidence, and the only evidence, that the Warrant Certificate so countersigned has been duly issued hereunder. 
 
In case any officer of the Company who shall have signed any of the Warrant Certificates either manually or by facsimile signature shall
cease to be such officer before the Warrant Certificates so signed shall have been countersigned and delivered by the Warrant Agent as provided herein, such Warrant Certificates may be 
 

2 

countersigned and delivered notwithstanding that the person who signed such Warrant Certificates ceased to
be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by such persons as, at the actual date of the execution of such Warrant Certificate, shall be the proper officers of the Company, although at the date
of the execution of this Agreement any such person was not such officer. 
 
The term “Holder”, when used with respect to any Warrant Certificate, shall mean any person in whose name at the time such Warrant Certificate shall be registered upon the books to be maintained by the Warrant
Agent for that purpose [2: or, prior to the Detachable Date, any person in whose name at the time the Offered Security to which such Warrant Certificate is attached is registered upon the register of the Offered Securities. Prior to the Detachable
Date, the Company will, or will cause the registrar of the Offered Securities to, make available at all times to the Warrant Agent such information as to holders of the Offered Securities with Warrants as may be necessary to keep the Warrant
Agent’s records up to date.] 
 
SECTION
1.03.    Issuance of Warrant Certificates.    Warrant Certificates evidencing the right to purchase [             shares of the Warrant
Securities] [an aggregate principal amount not exceeding $             of Warrant Securities] (except as provided in Sections 2.03, 3.02 and 4.01) may be executed by the Company and
delivered to the Warrant Agent upon the execution of this Warrant Agreement or from time to time thereafter. The Warrant Agent shall, upon receipt of Warrant Certificates duly executed on behalf of the Company, countersign Warrant Certificates
evidencing              Warrants representing the right to purchase up to [             shares of the Warrant Securities]
[$             aggregate principal amount of Warrant Securities] and shall deliver such Warrant Certificates to or upon the order of the Company. Subsequent to such original issuance of the
Warrant Certificates, the Warrant Agent shall countersign a Warrant Certificate only if the Warrant Certificate is issued in exchange or substitution for one or more previously countersigned Warrant Certificates or in connection with their transfer
as hereinafter provided or as provided in the penultimate paragraph of Section 2.03. 
 
Pending the preparation of definitive Warrant Certificates evidencing Warrants, the Company may execute and the Warrant Agent shall countersign and deliver temporary Warrant Certificates evidencing
such Warrants (printed, lithographed, typewritten or otherwise produced, in each case in form satisfactory to the Warrant Agent). Such temporary Warrant Certificates shall be issuable substantially in the form of the definitive Warrant Certificates
but with such omissions, insertions and variations as may be appropriate for temporary Warrant Certificates, all as may be determined by the Company with the concurrence of the Warrant Agent. Such temporary Warrant Certificates may contain such
reference to any provisions of this Warrant Agreement as may be appropriate. Every such temporary Warrant Certificate shall be executed by the Company and shall be countersigned by the Warrant Agent upon the same conditions and in substantially the
same manner, and with like effect, as the definitive Warrant Certificates. Without unreasonable delay, the Company shall execute and shall furnish definitive Warrant Certificates and thereupon such temporary Warrant Certificates may 
 

3 

be surrendered in exchange therefor without charge pursuant to and subject to the provisions of Section
4.01, and the Warrant Agent shall countersign and deliver in exchange for such temporary Warrant Certificates definitive Warrant Certificates of authorized denominations evidencing a like aggregate number of Warrants evidenced by such temporary
Warrant Certificates. Until so exchanged, such temporary Warrant Certificates shall be entitled to the same benefits under this Warrant Agreement as definitive Warrant Certificates. 
 
ARTICLE II 
 
WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS 
 
SECTION 2.01.    Warrant Price.    On
            ,             , the exercise price of each Warrant will be
            . During the period from             ,             
through and including             ,             , the exercise price of each Warrant will be
             [plus [accrued amortization of the original issue discount] [accrued interest] from             ,
            .] [In each case, the original issue discount will be amortized at a             % annual rate, computed on an annual
basis using the “interest” method and using a 360-day year consisting of twelve 30-day months]. Such exercise price of Warrant Securities is referred to in this Agreement as the “Warrant Price”. [The original issue discount for
each principal amount of Warrant Securities is             ]. 
 
SECTION 2.02.    Duration of Warrants.    [Subject to Section 4.03(b),] each Warrant may be
exercised [in whole but not in part] [in whole or in part] [at any time, as specified herein, on or after [the date thereof] [            ,
            ] and at or before [time, location] on             ,
             (each day during such period may hereinafter be referred to as an “Exercise Date”)] [on [list of specific dates] (each, an “Exercise Date”)], or such later
date as the Company may designate by notice to the Warrant Agent and the Holders of Warrant Certificates [in registered form and to the beneficial owners of the global Warrant Certificate] (the “Expiration Date”). Each Warrant not
exercised at or before [time, location] on the Expiration Date shall become void, and all rights of the Holder [and any beneficial owners] of the Warrant Certificate evidencing such Warrant under this Agreement shall cease. 
 
SECTION 2.03.    Exercise of
Warrants.    During the period specified in Section 2.02, any whole number of Warrants may be exercised by providing certain information as set forth on the reverse side of the Warrant Certificates evidencing such Warrants
and by paying in full [in lawful money of the United States of America] [in applicable currency] [in cash] [by certified check or official bank check or by bank wire transfer, in each case,] [by bank wire transfer] [in immediately available funds,]
the Warrant Price for each Warrant exercised [(plus accrued interest, if any, on the Warrant Securities to be issued upon exercise of such Warrant from and including the Interest Payment Date (as defined in the Indenture), if any, in respect of such
Warrant Securities immediately preceding the Exercise Date to and including the Exercise Date (unless the Exercise Date is after the Regular Record Date (as defined in the Indenture), if any, for such Interest Payment Date, but on or before the
immediately succeeding Interest Payment Date for such Warrant Securities, in which event no such accrued interest shall 
 

4 

be payable in respect of Warrant Securities to be issued in registered form))] to the Warrant Agent at its
corporate trust office at [address] [or at             ], provided that such exercise is subject to receipt within five business days of such [payment] [wire transfer] by the Warrant Agent
of the Warrant Certificate evidencing each Warrant exercised with the form of election to purchase Warrant Securities set forth on the reverse side of the Warrant Certificate properly completed and duly executed. 
 
[Insert Cashless Exercise Option provisions, if applicable]

 
The date on which payment in full of the Warrant
Price (plus any such accrued interest) is received by the Warrant Agent shall, subject to receipt of the Warrant Certificate as aforesaid, be deemed to be the date on which the Warrant is exercised. The Warrant Agent shall deposit all funds received
by it in payment for the exercise of Warrants in an account of the Company maintained with it (or in such other account as may be designated by the Company) and shall advise the Company, by telephone or by facsimile transmission or other form of
electronic communication available to both parties, at the end of each day on which a payment for the exercise of Warrants is received of the amount so deposited to its account. The Warrant Agent shall promptly confirm such advice to the Company in
writing. 
 
If a day on which Warrants may be
exercised in the city in which such Warrants are to be exercised shall be a Saturday or Sunday or a day on which banking institutions in such city are authorized or required to be closed, then, notwithstanding any other provision of this Agreement
or the Warrant Certificate evidencing such Warrants, but subject to the limitation that no Warrant may be exercised after the Expiration Date, the Warrants shall be exercisable on the next succeeding day which in such city is not a Saturday or
Sunday or a day on which banking institutions in such city are authorized or required to be closed. 
 
The Warrant Agent shall, from time to time, as promptly as practicable, advise the Company and the Trustee in writing of (i) the number of
Warrants exercised, (ii) the instructions of each Holder of the Warrant Certificates evidencing such Warrants with respect to delivery of the Warrant Securities to be issued upon such exercise, (iii) delivery of any Warrant Certificates evidencing
the balance, if any, of the Warrants remaining after such exercise, and (iv) such other information as the Company or the Trustee shall reasonably require. 
 
As soon as practicable after the exercise of any Warrant, but subject to receipt by the Warrant Agent of the Warrant Certificate
evidencing such Warrant as provided in this Section, the Company shall issue[, pursuant to the Indenture, in authorized denominations to or upon the order of the Holder of the Warrant Certificate evidencing each Warrant,] the Warrant Securities to
which such Holder is entitled, in fully registered form, registered in such name or names as may be directed by such Holder. If fewer than all of the Warrants evidenced by such Warrant Certificate are exercised, the Company shall execute, and an
authorized officer of the Warrant Agent shall manually countersign and deliver, a new Warrant Certificate evidencing the number of such Warrants remaining unexercised. 
 

5 

The Company shall not be required to pay any stamp or other tax or other governmental
charge required to be paid in connection with any transfer involved in the issuance of the Warrant Securities, and in the event that any such transfer is involved, the Company shall not be required to issue or deliver any Warrant Security until such
tax or other charge shall have been paid or it has been established to the Company’s satisfaction that no such tax or other charge is due. 
 
ARTICLE III 
 
OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS OF WARRANT 
 
SECTION 3.01.    No Rights as Warrant Securityholder Conferred by Warrant or Warrant
Certificates.    No Warrant Certificate or Warrant evidenced thereby shall entitle the Holder or any beneficial owner thereof to any of the rights of a holder or beneficial owner of Warrant Securities, including, without
limitation, [the right to receive the payment of principal of (premium, if any) or interest, if any, on Warrant Securities or to enforce any of the covenants in the Indenture] [the right to receive dividend payments on the Warrant Securities or any
voting rights]. 
 
SECTION
3.02.    Lost, Mutilated, Stolen, or Destroyed Warrant Certificates.    Upon receipt by the Warrant Agent of evidence reasonably satisfactory to it and the Company of the ownership of and the loss,
mutilation, theft or destruction of any Warrant Certificate and of such security or indemnity as may be required by the Company and the Warrant Agent to hold each of them and any agent of them harmless and, in the case of mutilation of a Warrant
Certificate, upon surrender thereof to the Warrant Agent for cancellation, then, in the absence of notice to the Company or the Warrant Agent that such Warrant Certificate has been acquired by a bona fide purchaser, the Company shall execute, and an
authorized officer of the Warrant Agent shall manually countersign and deliver, in exchange for or in lieu of the lost, mutilated, stolen or destroyed Warrant Certificate, a new Warrant Certificate of the same tenor and evidencing a like number of
Warrants. Upon the issuance of any new Warrant Certificate under this Section, the Company may require the payment of a sum sufficient to cover any stamp or other tax or other governmental charge that may be imposed in relation thereto and any other
expenses (including the fees and expenses of the Warrant Agent) in connection therewith. Every substitute Warrant Certificate executed and delivered pursuant to this Section in lieu of any lost, mutilated, stolen or destroyed Warrant Certificate
shall represent an additional contractual obligation of the Company, whether or not the lost, stolen or destroyed Warrant Certificate shall be at any time enforceable by anyone, and shall be entitled to the benefits of this Agreement equally and
proportionately with any and all other Warrant Certificates duly executed and delivered hereunder. The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement
of lost, mutilated, stolen or destroyed Warrant Certificates. 
 
SECTION 3.03.    Enforcement of Rights.    Notwithstanding any of the provisions of this Agreement, any Holder of a Warrant Certificate, without the consent of the Warrant Agent, the
Trustee, the holder of any Offered Securities or the Holder of any 
 

6 

other Warrant Certificate, may, in its own behalf and for its own benefit, enforce, and may institute and
maintain any suit, action or proceeding against the Company suitable to enforce, or otherwise in respect of, its right to exercise its Warrants in the manner provided in its Warrant Certificate and in this Agreement. 
 
SECTION 3.04.    Merger, Consolidation,
Conveyance or Transfer.    (a) If at any time there shall be a merger or consolidation of the Company or a conveyance or transfer of its property and assets substantially as an entirety [as permitted under the Indenture],
then in any such event the successor or assuming corporation referred to therein shall succeed to and be substituted for the Company, with the same effect [, subject to the Indenture,] as if it had been named herein and in the Warrant Certificates
as the Company; the Company shall thereupon, except in the case of a transfer by way of lease, be relieved of any further obligation hereunder and under the Warrants and the Warrant Certificates, and the Company as the predecessor corporation,
except in the case of a transfer by way of lease, may thereupon or at any time thereafter be dissolved, wound up or liquidated. Such successor or assuming corporation may thereupon cause to be signed, and may issue either in its own name or in the
name of the Company, Warrant Certificates evidencing any or all of the Warrants issuable hereunder which theretofore shall not have been signed by the Company, and may execute and deliver Warrant Securities in its own name [, pursuant to the
Indenture,] in fulfillment of its obligations to deliver Warrant Securities upon exercise of the Warrants. All the Warrants so issued shall in all respects have the same legal rank and benefit under this Agreement as the Warrants theretofore or
thereafter issued in accordance with the terms of this Agreement as though all of such Warrants had been issued at the date of the execution hereof. In any case of any such merger, consolidation, conveyance or transfer, such changes in phraseology
and form (but not in substance) may be made in the Warrant Certificates representing the Warrants thereafter to be issued as may be appropriate. 
 
(b)  The Warrant Agent may receive a written opinion of legal counsel (who shall be acceptable to the Warrant Agent) as
conclusive evidence that any such merger, consolidation, conveyance or transfer complies with the provisions of this Section and the Indenture. 
 
[Add Anti-Dilution provisions as necessary.] 
 
ARTICLE IV 
 
EXCHANGE AND TRANSFER 
 
SECTION 4.01.    Exchange and Transfer.    (a)  [1: Upon] [2: Prior to the
Detachable Date, a Warrant Certificate may be exchanged or transferred only together with the Offered Security to which such Warrant Certificate was initially attached, and only for the purpose of effecting, or in conjunction with, an exchange or
transfer of such Offered Security. Prior to any Detachable Date, each transfer of the Offered Security, shall operate also to transfer the related Warrant Certificates. On or after the Detachable Date, upon] surrender at the corporate trust office
of the Warrant Agent at [address] [or             ], Warrant Certificates evidencing Warrants may be exchanged for Warrant 
 

7 

Certificates in other authorized denominations evidencing such Warrants or the transfer thereof may be
registered in whole or in part; provided, however, that such other Warrant Certificates shall evidence the same aggregate number of Warrants as the Warrant Certificates so surrendered. 
 
(b)  The Warrant Agent shall keep, at its corporate trust office at [address] [and at
            ], books in which, subject to such reasonable regulations as it may prescribe, it shall register Warrant Certificates and exchanges and transfers of outstanding Warrant
Certificates upon surrender of such Warrant Certificates to the Warrant Agent at its corporate trust office at [address] [or             ] for exchange or registration of transfer, properly
endorsed [or accompanied by appropriate instruments of registration of transfer and written instructions for transfer, all in form satisfactory to the Company and the Warrant Agent.] 
 
(c)  No service charge shall be made for any exchange or registration of transfer of Warrant
Certificates, but the Company may require payment of a sum sufficient to cover any stamp or other tax or other governmental charge that may be imposed in connection with any such exchange or registration of transfer. 
 
(d)  Whenever any Warrant Certificates are so
surrendered for exchange or registration of transfer, an authorized officer of the Warrant Agent shall manually countersign and deliver to the person or persons entitled thereto a Warrant Certificate or Warrant Certificates, duly authorized and
executed by the Company, as so requested. The Warrant Agent shall not effect any exchange or registration of transfer which will result in the issuance of a Warrant Certificate, evidencing a fraction of a Warrant or a number of full Warrants and a
fraction of a Warrant. 
 
(e)  All
Warrant Certificates issued upon any exchange or registration of transfer of Warrant Certificates shall be the valid obligations of the Company evidencing the same obligations, and entitled to the same benefits under this Agreement, as the Warrant
Certificates surrendered for such exchange or registration or transfer. 
 
SECTION 4.02.    Treatment of Holders of Warrant Certificates.    Each Holder of a Warrant Certificate, by accepting the same, consents and agrees with the Company, the Warrant
Agent and every subsequent Holder of such Warrant Certificate that until the transfer of such Warrant Certificate is registered on the books of such Warrant Agent [2: or, prior to the Detachable Date, until the transfer of the Offered Security to
which such Warrant Certificate is attached is registered in the register of the Offered Securities], the Company and the Warrant Agent may treat the registered Holder of such Warrant Certificate as the absolute owner thereof for any purpose and as
the person entitled to exercise the rights represented by the Warrants evidenced thereby, any notice to the contrary notwithstanding. 
 
SECTION 4.03.    Cancellation of Warrant Certificates.    [(a)]  Any Warrant
Certificate surrendered for exchange or registration of transfer or exercise of the Warrants evidenced thereby shall, if surrendered to the Company, be delivered to the 
 

8 

Warrant Agent, and all Warrant Certificates surrendered or so delivered to the Warrant Agent shall be
promptly cancelled by the Warrant Agent and shall not be reissued and, except as expressly permitted by this Agreement, no Warrant Certificate shall be issued hereunder in exchange therefor or in lieu thereof. The Warrant Agent shall cause all
cancelled Warrant Certificates to be destroyed and shall deliver a certificate of such destruction to the Company. 
 
[(b)  If the Company notifies the Trustee of its election to redeem [2: prior to the Detachable Date] [, as a whole but not in
part,] [2: the Offered Securities [or] [and]] the Warrant Securities pursuant to the Indenture or the terms thereof, the Company may elect, and shall give notice to the Warrant Agent of its election, to cancel the unexercised Warrants, the Warrant
Certificates and the rights evidenced thereby. Promptly after receipt of such notice by the Warrant Agent, the Company shall, or, at the Company’s request, the Warrant Agent shall in the name of and at the expense of the Company, give notice of
such cancellation to the Holders of the Warrant Certificates, such notice to be so given not less than 30 nor more than 60 days prior to the date fixed for the redemption of [2: the Offered Securities [or] [and]] the Warrant Securities pursuant to
the Indenture or the terms thereof. The unexercised Warrants, the Warrant Certificates and the rights evidenced thereby shall be cancelled and become void on the 15th day prior to such date fixed for redemption.] 
 
ARTICLE V 
 
CONCERNING THE WARRANT AGENT 
 
SECTION 5.01.    Warrant
Agent.    The Company hereby appoints              as Warrant Agent of the Company in respect of the Warrants and the Warrant Certificates upon the terms and subject
to the conditions herein and in the Warrant Certificates set forth; and              hereby accepts such appointment. The Warrant Agent shall have the powers and authority granted to and
conferred upon it in the Warrant Certificates and herein and such further powers and authority to act on behalf of the Company as the Company may hereafter grant to or confer upon it. 
 
All of the terms and provisions with respect to such powers and authority contained in the Warrant
Certificates are subject to and governed by the terms and provisions hereof. 
 
SECTION 5.02.    Conditions of Warrant Agent’s Obligations.    The Warrant Agent accepts its obligations herein set forth upon the terms and
conditions hereof, including the following, to all of which the Company agrees and to all of which the rights hereunder of the Holders from time to time of the Warrant Certificates shall be subject: 
 
(a)  Compensation and Indemnification. The Company
agrees promptly to pay the Warrant Agent the compensation to be agreed upon with the Company for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses (including reasonable
attorneys’ fees) 
 

9 

incurred by the Warrant Agent without negligence, bad faith or breach of this Agreement on its part in
connection with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent for, and to hold it harmless against, any loss, liability or expense incurred without negligence or bad faith on the part of
the Warrant Agent, arising out of or in connection with its acting as Warrant Agent hereunder, as well as the reasonable costs and expenses of defending against any claim of such liability. 
 
(b)  Agent for the Company. In acting under this
Agreement and in connection with the Warrants and the Warrant Certificates, the Warrant Agent is acting solely as agent of the Company and does not assume any obligation or relationship of agency or trust for or with any of the Holders of Warrant
Certificates or beneficial owners of Warrants. 
 
(c)  Counsel. The Warrant Agent may consult with counsel satisfactory to it in its reasonable judgment, and the advice of such counsel shall be full and complete authorization and protection in respect of any action taken,
suffered or omitted by it hereunder in good faith and in accordance with the advice of such counsel. 
 
(d)  Documents. The Warrant Agent shall be protected and shall incur no liability for or in respect of any action taken or thing
suffered by it in reliance upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or document reasonably believed by it to be genuine and to have been presented or signed by the proper parties.

 
(e)  Certain Transactions. The Warrant
Agent, and its officers, directors and employees, may become the owner of, or acquire any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted by applicable
law, it or they may engage or be interested in any financial or other transaction with the Company and may act on, or as depositary, trustee or agent for, any committee or body of holders of Warrant Securities or other obligations of the Company as
freely as if it were not the Warrant Agent hereunder. [Nothing in this Warrant Agreement shall be deemed to prevent the Warrant Agent from acting as Trustee under the Indenture.] 
 
(f)  No Liability for Interest. The Warrant Agent shall have no liability for interest on any
monies at any time received by it pursuant to any of the provisions of this Agreement or of the Warrant Certificates. 
 
(g)  No Liability for Invalidity. The Warrant Agent shall not be under any responsibility with respect to the validity or
sufficiency of this Agreement or the execution and delivery hereof (except the due authorization to execute this Agreement and the due execution and delivery hereof by the Warrant Agent) or with respect to the validity or execution of any Warrant
Certificates (except its countersignature thereof). 
 

10 

(h)  No Liability for Recitals. The recitals contained herein shall be taken as
the statements of the Company, and the Warrant Agent assumes no liability for the correctness of the same. 
 
(i)  No Implied Obligations. The Warrant Agent shall be obligated to perform only such duties as are herein and in the Warrant
Certificates specifically set forth and no implied duties or obligations shall be read into this Agreement or the Warrant Certificates against the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder which
may tend to involve it in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion, assured to it. The Warrant Agent shall not be accountable or under any duty or responsibility for the use by the
Company of any of the Warrant Certificates countersigned by the Warrant Agent and delivered by it to the Company pursuant to this Agreement or for the application by the Company of the proceeds of the Warrant Certificates. The Warrant Agent shall
have no duty or responsibility in case of any default by the Company in the performance of its covenants or agreements contained herein or in the Warrant Certificates or in the case of the receipt of any written demand from a Holder of a Warrant
Certificate with respect to such default, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or, except as provided in Section 6.02, to make
any demand upon the Company. 
 
SECTION
5.03.    Resignation and Appointment of Successor.    (a) The Company agrees, for the benefit of the Holders from time to time of the Warrant Certificates, that there shall at all times be a Warrant
Agent hereunder until all the Warrants have been exercised or are no longer exercisable. 
 
(b)  The Warrant Agent may at any time resign as such by giving written notice of its resignation to the Company, specifying the desired date on which its resignation shall become effective;
provided, however, that such date shall be not less than 90 days after the date on which such notice is given unless the Company agrees to accept shorter notice. Upon receiving such notice of resignation, the Company shall promptly appoint a
successor Warrant Agent (which shall be a bank or trust company in good standing, authorized under the laws of the jurisdiction of its organization to exercise corporate trust powers) by written instrument in duplicate signed on behalf of the
Company, one copy of which shall be delivered to the resigning Warrant Agent and one copy to the successor Warrant Agent. The Company may, at any time and for any reason, remove the Warrant Agent and appoint a successor Warrant Agent (qualified as
aforesaid) by written instrument in duplicate signed on behalf of the Company and specifying such removal and the date when it is intended to become effective, one copy of which shall be delivered to the Warrant Agent being removed and one copy to
the successor Warrant Agent. Any resignation or removal of the Warrant Agent and any appointment of a successor Warrant Agent shall become effective upon acceptance of appointment by the successor Warrant Agent as provided in this subsection (b). In
the event a successor Warrant Agent has not been appointed and accepted its duties within 90 days of the Warrant Agent’s notice of resignation, the Warrant Agent may apply to any court of competent jurisdiction for the designation of a
successor Warrant Agent. Upon 
 

11 

its resignation or removal, the Warrant Agent shall be entitled to the payment by the Company of the
compensation and to the reimbursement of all reasonable out-of-pocket expenses (including reasonable attorneys’ fees) incurred by it hereunder as agreed to in Section 5.02(a). 
 
(c)  The Company shall remove the Warrant Agent and appoint a successor Warrant Agent if the
Warrant Agent (i) shall become incapable of acting, (ii) shall be adjudged bankrupt or insolvent, (iii) shall commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to it or its debts under any
bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any substantial part of its property, (iv) shall consent to, or shall
have had entered against it a court order for, any such relief or to the appointment of or taking possession by any such official in any involuntary case or other proceedings commenced against it, (v) shall make a general assignment for the benefit
of creditors or (vi) shall fail generally to pay its debts as they become due. Upon the appointment as aforesaid of a successor Warrant Agent and acceptance by it of such appointment, the predecessor Warrant Agent shall, if not previously
disqualified by operation of law, cease to be Warrant Agent hereunder. 
 
(d)  Any successor Warrant Agent appointed hereunder shall execute, acknowledge and deliver to its predecessor and the Company an instrument accepting such appointment hereunder, and thereupon such successor
Warrant Agent, without any further act, deed or conveyance, shall become vested with all the authority, rights, powers, immunities, duties and obligations of such predecessor with like effect as if originally named as Warrant Agent hereunder, and
such predecessor shall thereupon become obligated to transfer, deliver and pay over, and such successor Warrant Agent shall be entitled to receive, all monies, securities and other property on deposit with or held by such predecessor as Warrant
Agent hereunder. 
 
(e)  Any corporation
into which the Warrant Agent hereunder may be merged or converted or any corporation with which the Warrant Agent may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a
party, or any corporation to which the Warrant Agent shall sell or otherwise transfer all or substantially all the assets and business of the Warrant Agent, provided that it shall be qualified as aforesaid, shall be the successor Warrant Agent under
this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto. 
 
ARTICLE VI 
 
MISCELLANEOUS 
 
SECTION 6.01.    Amendment.    This Agreement and the terms of the Warrants and the Warrant
Certificates may be amended by the parties hereto, without the consent of the Holder of any Warrant Certificate or the beneficial owner of any Warrant, for the purpose of curing any ambiguity, or of curing, correcting or supplementing any

 

12 

defective or inconsistent provision contained herein or in the Warrant Certificates, or making any other
provisions with respect to matters or questions arising under this Agreement as the Company and the Warrant Agent may deem necessary or desirable, provided that such action shall not affect adversely the interests of the Holders of the Warrant
Certificates or the beneficial owners of Warrants in any material respect. 
 
SECTION 6.02.    Notices and Demands to the Company and Warrant Agent.    If the Warrant Agent shall receive any notice or demand addressed to the Company
by the Holder of a Warrant Certificate pursuant to the provisions of the Warrant Certificates, the Warrant Agent shall promptly forward such notice or demand to the Company. 
 
SECTION 6.03.    Addresses.    Any communication from the
Company to the Warrant Agent with respect to this Agreement shall be addressed to             , Attention:             , and any
communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Black Hills Corporation, 625 Ninth Street, P.O. Box 1400, Rapid City, South Dakota 57701, Attention:
             (or such other address as shall be specified in writing by the Warrant Agent or by the Company). 
 
SECTION 6.04.    Applicable Law.    The validity,
interpretation and performance of this Agreement and each Warrant Certificate issued hereunder and of the respective terms and provisions hereof and thereof shall be governed by, and construed in accordance with, the laws of the State of New York.

 
SECTION 6.05.    Delivery
of Prospectus.    The Company will furnish to the Warrant Agent sufficient copies of a prospectus relating to the Warrant Securities deliverable upon exercise of Warrants (the “Prospectus”), and the Warrant Agent
agrees that upon the exercise of any Warrant, the Warrant Agent will deliver to the Holder of the Warrant Certificate evidencing such Warrant, prior to or concurrently with the delivery of the Warrant Securities issued upon such exercise, a
Prospectus. The Warrant Agent shall not, by reason of any such delivery, assume any responsibility for the accuracy or adequacy of such Prospectus. 
 
SECTION 6.06.    Obtaining of Governmental Approval.    The Company will from time to time
take all action which may be necessary to obtain and keep effective any and all permits, consents and approvals of governmental agencies and authorities and securities acts filings under United States federal and state laws (including without
limitation a registration statement in respect of the Warrants and Warrant Securities under the Securities Act of 1933, as amended), which may be or become requisite in connection with the issuance, sale, transfer and delivery of the Warrant
Certificates, the exercise of the Warrants, the issuance, sale, transfer and delivery of the Warrant Securities issued upon exercise of the Warrants or upon the expiration of the period during which the Warrants are exercisable. 
 
SECTION 6.07.    Persons Having Rights
under Warrant Agreement.    Nothing in this Agreement shall give to any person other than the Company, the Warrant 
 

13 

Agent and the Holders of the Warrant Certificates any right, remedy or claim under or by reason of this
Agreement. 
 
SECTION
6.08.    Headings.    The descriptive headings of the several Articles and Sections of this Agreement are inserted for convenience only and shall not control or affect the meaning or construction of any
of the provisions hereof. 
 
SECTION
6.09.    Counterparts.    This Agreement may be executed in any number of counterparts, each of which as so executed shall be deemed to be an original, but such counterparts shall together constitute
but one and the same instrument. 
 
SECTION
6.10.    Inspection of Agreement.    A copy of this Agreement shall be available at all reasonable times at the principal corporate trust office of the Warrant Agent for inspection by the Holder of any
Warrant Certificate. The Warrant Agent may require such Holder to submit its Warrant Certificate to the Warrant Agent for review prior to such inspection. 
 
SECTION 6.11.    Notices to Holders of Warrants.    Any notice to Holders of Warrants
evidenced by Warrant Certificates which by any provisions of this Warrant Agreement is required or permitted to be given shall be given by first class mail prepaid at such Holder’s address as it appears on the books of the Warrant Agent.

 

14 

 
IN WITNESS
WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written. 
 

	  BLACK HILLS CORPORATION

	
	  By:
	  	   

	  	  	  Name:
  Title:

 

	  [WARRANT AGENT]

	
	  By:
	  	   

	  	  	  Name:
  Title:

 

15 

 
EXHIBIT A

 
[FORM OF WARRANT CERTIFICATE] 
 
[Face] 
 
[Prior to
            , this Warrant Certificate may be transferred or exchanged if and only if the [title of Offered Security] to which it was initially attached is so transferred or exchanged.]

 
[Prior to
            , Warrants evidenced by this Warrant Certificate cannot be exercised.] 
 
EXERCISABLE ONLY IF AUTHENTICATED BY THE WARRANT 
AGENT AS PROVIDED HEREIN 
 
VOID AFTER THE CLOSE OF BUSINESS ON             ,              
 
BLACK HILLS CORPORATION 
 
Warrant Certificate representing 
Warrants to purchase 
[Title of Warrant Securities] 
as described herein 
 

 

	  No.             
             
	               Warrants 

 
This certifies that
[                        ] or registered assigns is the registered owner of the above indicated number of Warrants, each Warrant
entitling such registered owner to purchase, at any time [after the close of business on             ,             , and] on or
before the close of business on             ,             ,
[             shares of [title of Warrant Securities]] [$             aggregate principal amount of [title of Warrant
Securities]] (the “Warrant Securities”) of Black Hills Corporation (the “Company”) [, issued or to be issued under the Indenture (as hereinafter defined),] on the following basis.2 [During the period from             ,
             through and including             ,             , each
Warrant shall entitle the Holder thereof, subject to the provisions of this Agreement, to purchase from the Company the [principal] amount of Warrant Securities stated above in this Warrant Certificate at the exercise price of
[            ] [            % of the principal amount thereof [plus accrued amortization, if any, of the original issue discount
of the Warrant Securities][plus accrued interest, if any, from the most recent date from 

	  2	  	  Complete and modify the following provisions as appropriate to reflect the terms of the
Warrants and the Warrant Securities. 

 

A-1 

 
which interest shall have been
paid on the Warrant Securities or, if no interest shall have been paid on the Warrant Securities, from             ,
            ]; [in each case, the original issue discount ($             for each $1,000 principal amount of Warrant Securities)
will be amortized at a             % annual rate, computed on a[n] [semi-]annual basis[, using a 360-day year constituting of twelve 30-day months]] (the “Exercise Price”). The
Holder of this Warrant Certificate may exercise the Warrants evidenced hereby, in whole or in part, by surrendering this Warrant Certificate, with the purchase form set forth hereon duly completed, accompanied [by payment in full, in lawful money of
the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds]], the Exercise Price for each Warrant exercised, to the Warrant Agent (as
hereinafter defined), at the corporate trust office of [name of Warrant Agent], or its successor as warrant agent (the “Warrant Agent”), at the addresses specified on the reverse hereof [or at
            ] and upon compliance with and subject to the conditions set forth herein and in the Warrant Agreement (as hereinafter defined). This Warrant Certificate may be exercised only
for the purchase of [             shares of] Warrant Securities [in the principal amount of $            ] or any integral
multiple thereof. 
 
[Insert Cashless Exercise
Option provisions, if applicable] 
 
The term
“Holder” as used herein shall mean[, prior to             ,              (the “Detachable Date”), the
registered owner of the Company’s [title of Offered Securities] to which such Warrant Certificate was initially attached, and after such Detachable Date,] the person in whose name at the time such Warrant Certificate shall be registered upon
the books to be maintained by the Warrant Agent for that purpose pursuant to the Warrant Agreement. 
 
Any whole number of Warrants evidenced by this Warrant Certificate may be exercised to purchase Warrant Securities in registered form.
Upon any exercise of fewer than all of the Warrants evidenced by this Warrant Certificate, there shall be issued to the registered owner hereof a new Warrant Certificate evidencing the number of Warrants remaining unexercised. 
 
This Warrant Certificate is issued under and in accordance
with the Warrant Agreement dated as of             ,              (the “Warrant Agreement”), between the Company and
the Warrant Agent and is subject to the terms and provisions contained in the Warrant Agreement, to all of which terms and provisions the Holder of this Warrant Certificate consents by acceptance hereof. Copies of the Warrant Agreement are on file
at the above-mentioned office of the Warrant Agent [and at             ]. 
 
[The Warrant Securities to be issued and delivered upon the exercise of Warrants evidenced by this Warrant Certificate will be issued
under and in accordance with an Indenture, dated as of              (the “Indenture”), between the Company and
            , a [corporation] [national banking association] organized under the laws of the State of             , as trustee
(such trustee, and any successors to such trustee, the “Trustee”) and will be subject to the terms and provisions contained in the Warrant Securities and in the Indenture. Copies of the Indenture, 
 

A-2 

 
including the form of the
Warrant Securities, are on file at the corporate trust office of the Trustee [and at             ].] 
 
[Prior to             ,
             (the “Detachable Date”), this Warrant Certificate may be exchanged or transferred only together with the [title of Offered Security] (the “Offered
Security”) to which this Warrant Certificate was initially attached, and only for the purpose of effecting, or in conjunction with, an exchange or transfer of such Offered Security. Additionally, on or prior to the Detachable Date, each
transfer of such Offered Security on the register of the Offered Securities shall operate also to transfer this Warrant Certificate. After the Detachable Date,] this Warrant Certificate, and all rights hereunder, may be transferred when surrendered
at the corporate trust office of the Warrant Agent [or             ] by the registered owner or its assigns, in person or by an attorney duly authorized in writing, in the manner and
subject to the limitations provided in the Warrant Agreement. 
 
Except as provided in the immediately preceding paragraph, after authentication by the Warrant Agent and prior to the expiration of this Warrant Certificate, this Warrant Certificate may be exchanged at the corporate trust office of
the Warrant Agent [or at             ] for Warrant Certificates representing the same aggregate number of Warrants. 
 
This Warrant Certificate shall not entitle the registered owner hereof to any of the rights of a registered
holder of the Warrant Securities, including, without limitation, [the right to receive payments of principal of (and premium, if any) or interest, if any, on the Warrant Securities or to enforce any of the covenants of the Indenture] [the right to
receive dividend payments on the Warrant Securities or any voting rights]. 
 
Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at
this place. 
 
This Warrant Certificate shall not
be valid or obligatory for any purpose until authenticated by the Warrant Agent. 
 

A-3 

 
IN WITNESS
WHEREOF, the Company has caused this Warrant Certificate to be duly executed as of the date hereof. 
 
Dated:                      
 

	  BLACK HILLS CORPORATION

	
	  By:
	  	   

	  	  	  Name:
  Title:

 
CERTIFICATE OF AUTHENTICATION 
 
This is one of the Warrant Certificates referred to in the within-mentioned Warrant Agreement. 
 
 

	
  As Warrant
Agent

	
	  By:
	  	   

	  	  	  Authorized Signature

 

A-4 

 
[FORM OF
WARRANT CERTIFICATE] 
 
[Reverse] 
 
(Instructions for exercise of Warrants) 
 
To exercise any Warrants evidenced hereby, the Holder of this
Warrant Certificate must pay [in cash or by certified check or official bank check in New York Clearing House funds or by bank wire transfer in immediately available funds], the Exercise Price in full for each of the Warrants exercised, to
            , Corporate Trust Department,             , Attn:
             [or             ], which payment should specify the name of the Holder of this Warrant Certificate and the number of
Warrants exercised by such Holder. In addition, the Holder of this Warrant Certificate should complete the information required below and present in person or mail by registered mail this Warrant Certificate to the Warrant Agent at the addresses set
forth below. 
 
[FORM OF EXERCISE] 
 
(To be executed upon exercise of Warrants) 
 
The undersigned hereby irrevocably elects to exercise
             Warrants, represented by this Warrant Certificate, to purchase [             shares of [title of Warrant
Securities]] [$             aggregate principal amount of the [title of Warrant Securities]] (the “Warrant Securities”) of BLACK HILLS CORPORATION and represents that he has
tendered payment for such Warrant Securities [in cash or by certified check or official bank check in New York Clearing House funds or by bank wire transfer in immediately available funds] to the order of Black Hills Corporation, c/o Treasurer in
the amount of $             in accordance with the terms hereof. The undersigned requests that said [principal] amount of Warrant Securities be in fully registered form, in the authorized
denominations, registered in such names and delivered, all as specified in accordance with the instructions set forth below. 
 
If said [principal] amount of Warrant Securities is less than all of the Warrant Securities purchasable hereunder, the undersigned
requests that a new Warrant Certificate representing the remaining balance of the Warrants evidenced hereby be issued and delivered to the undersigned unless otherwise specified in the instructions below. 
 
Dated:                     
 

	  Name:

	
	

	  (Please Print)

 

	
	

	  (Insert Social Security or Other
  Identifying Number of Holder)

 

A-5 

 

	  Address:
   

   

	
	  Signature:
   

	  (Signed exactly as name appears on the
  other side of this Warrant Certificate)

 
This Warrant may be exercised at the following addresses: 
 
By hand at: 
 

 

 

 
By mail at: 

 

 

 
(Instructions as to form and delivery of Warrant Securities
and/or Warrant Certificates): 
 

A-6 

 
[FORM OF
ASSIGNMENT] 
 
(To be executed to transfer the
Warrant Certificate) 
 
FOR VALUE RECEIVED
             hereby sells, assigns and transfers unto 
 

	
  Please insert social
security or other
  identifying number

	
	   

 
(Please print name and address
  including zip
code)

	  	  	  

 
                            the right represented by the within Warrant Certificate and does
hereby irrevocably constitute and appoint             , Attorney, to transfer said Warrant Certificate on the books of the Warrant Agent with full power of substitution. 
 
Dated:                         
 
 

	
  Signature
  (Signed exactly as name appears on the
  other side of this Warrant Certificate)

	
	  	  	  
	  	  	  

Signature Guarantee: 
 
 

	
	
  Participant in a
recognized Signature Guarantee
  Medallion Program (or other signature guarantor
  program reasonably acceptable to the Warrant Agent)

	  	  	  

 

A-7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]